Dr. Nikhil Suresh Ghadyalpatil is one of India’s leading medical oncologists and currently serves as director of medical oncology at Apollo Cancer Centre, Apollo Health City, Jubilee Hills, Hyderabad, where he is at the forefront of advancing precision oncology, evidence-based cancer care, and multidisciplinary treatment excellence. With nearly two decades of clinical, academic, and research experience, Dr. Ghadyalpatil has built an exceptional reputation for combining cutting-edge science with deeply compassionate patient care, helping thousands of patients navigate complex cancer journeys with confidence, dignity, and hope. His professional mission is centered on delivering personalized oncology solutions through the integration of chemotherapy, immunotherapy, targeted therapies, molecular oncology, and translational research.

Academically distinguished, Dr. Ghadyalpatil completed his MBBS before pursuing MD and DNB in internal medicine from the prestigious Seth G.S. Medical College and KEM Hospital, Mumbai. He later completed his super-specialization in medical oncology from the world-renowned Tata Memorial Hospital, Mumbai, one of Asia’s most respected cancer institutes. Further strengthening his global credentials, he earned the European Certification in Medical Oncology (ECMO), MRCP in Medical Oncology (SCE, UK), and advanced certifications in molecular oncology, reflecting his commitment to continuous scientific advancement and global best practices in cancer treatment.

Before joining Apollo Hospitals in Hyderabad, Dr. Ghadyalpatil served at Tata Memorial Centre and later spent over fifteen years as a consultant medical oncologist and clinical director at leading oncology institutions, building comprehensive cancer programs and mentoring the next generation of oncology specialists. At Apollo Cancer Centre, he leads one of the region’s most advanced medical oncology teams, with expertise spanning lung cancer, breast cancer, gastrointestinal malignancies, hematological cancers, gynecological cancers, sarcomas, and precision immuno-oncology.

A respected clinician-scientist, educator, and thought leader, Dr. Ghadyalpatil has authored numerous scientific publications, participated in international oncology research, and received prestigious recognitions, including the International Development and Education Award from the American Society of Clinical Oncology. Through his unwavering commitment to clinical excellence, research innovation, and patient-centered care, Dr. Nikhil Ghadyalpatil continues to redefine cancer care in India while contributing significantly to the global oncology community.